China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study of Neoadjuvant Toripalimab Combined with SBRT for Resectorable Clear Cell Renal Cell Carcinoma: A Prospective, Single-Arm, Phase II Clinical Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135610
Registration Time: 2026/10/30
Type: Interventional study
Primary Sponsor: Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345474
Published by HT Digital Content Services with permission from Health Daily Digest....